被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| Australia: Safety advisory: Resurrection Male Sexual Enhancement Capsules contain the undeclared substances sildenafil, tadalafil and dipyrone (English only) |
| |
Therapeutic Goods Administration (TGA) announces that it has tested a product labelled Resurrection Male Sexual Enhancement Capsules and found that the capsules contain the undeclared substances sildenafil, tadalafil and dipyrone. Consumers are advised that products which contain sildenafil and tadalafil are prescription-only medicines in Australia. Dipyrone is prohibited in Australia due to a rare life-threatening blood disorder called agranulocytosis. Consumers should stop taking Resurrection Male Sexual Enhancement Capsules and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their health care practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/resurrection-male-sexual-enhancement-capsules
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Thursday, Feb 11, 2021
Issued at HKT 15:00
|
| |
